This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Saijie Zhu: Innovator in Pharmaceutical Chemistry
Introduction
Saijie Zhu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents to his name, Zhu is recognized for his innovative approach to drug discovery.
Latest Patents
Zhu's latest patents focus on "Substituted bisphenyl butanoic ester derivatives as NEP inhibitors." The present disclosure provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R and R' are defined herein. The disclosure also relates to a method for manufacturing the compounds and their therapeutic uses. Furthermore, it provides pharmaceutical compositions of the compounds and combinations of pharmacologically active agents with the compounds.
Career Highlights
Saijie Zhu is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore innovative solutions in drug development, contributing to advancements in medical science.
Collaborations
Zhu has collaborated with notable colleagues, including Yongshuai Chai and Sven Erik Godtfredsen. These collaborations have fostered a dynamic environment for research and innovation.
Conclusion
Saijie Zhu's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key inventor in the industry. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile